When it comes to flu vaccination, nearly 50% of US adults don’t know the benefits. Are your patients among them?
Expert Insights: Q&A with Mark Ebell, MD, on Gepotidacin and UTI Management
Family physician and researcher Mark Ebell, MD, discusses the clinical implications, efficacy, and role of gepotidacin in UTI management.
Primary Viewpoints: Immunizations with Dr Steven P. Furr
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.
New Study Suggests Bacterial Vaginosis May be Sexually Transmitted
New research shows that treating both men and women with topical and oral antibiotics lowers the odds of bacterial vaginosis recurrence by more than half.
Respiratory Tripledemic 2022-23: An Expert Recap
William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.
FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs
Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.
Study: 72% of Asymptomatic UTI Patients Receive Unnecessary Antibiotics
Researchers recommend expanding antimicrobial stewardship efforts to better track and reduce unnecessary antibiotic use.